JP at large: When your advice is rejected

Researchers examined the factors attributed to self-reported resilience among diverse and community-dwelling adults during the COVID-19 pandemic.

Seven major clinical trials reveal semaglutide’s expanding benefits beyond glucose control, showing promise in kidney, heart, liver, vascular, and obesity-related outcomes.

New research reveals amoxicillin's effectiveness varies in treating invasive pneumococcal disease, highlighting the importance of patient-specific factors in antibiotic therapy.

With federal reform continuing to stall, Drug Topics caught up with Iowa State Representative Brett Barker, PharmD, to discuss how his state is regulating pharmacy benefit managers.

Older adults are more likely to have chronic diseases, such as lung disease or heart disease, which makes them more susceptible to invasive pneumococcal disease.

Thomas Sherrer, PharmD, advocates for a team-driven, tech-enhanced approach to pharmacy inventory management, boosting patient care and operational efficiency.